Medidata Solutions (MDSO) Tops Q4 EPS by 8c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Needham & Company Reiterates Hold on Medidata Solutions (MDSO) Following 4Q
February 13, 2019 9:19 AM ESTNeedham & Company analyst, Scott Berg, reiterated a Hold rating on Medidata Solutions (NASDAQ: MDSO) following the company's 4Q earnings report. 4Q revenue was ahead of consensus but the EPS outperformance was driven by a lower than guided tax rate.
Initial 2019 guidance is below... More
Jefferies Remains Sidelined on Medidata Solutions (MDSO)
February 13, 2019 9:16 AM ESTJefferies analyst, David Windley, reiterated a Hold rating and $76.00 price target on Medidata Solutions (NASDAQ: MDSO) following the company's 4Q report. MDSO had met or exceeded estimates through 3Q, but lost momentum in 4Q, slightly missing on revs & EBITDA. EBITDA margin for FY18... More

